Clinical Study
Comparing the Differential Diagnostic Values of 18F-Alfatide II PET/CT between Tuberculosis and Lung Cancer Patients
Table 3
SUVmax and SUVmean of lesions.
| | | 18F-FDG | 18F-Alfatide II | 18F-FDG | 18F-Alfatide II | | SUVmax | SUVmax | SUVmean | SUVmean |
| | Tuberculosis | 7.53 ± 2.88 | 2.63 ± 1.34 | 4.58 ± 1.73 | 1.86 ± 1.0 | | Lung cancer | 12.04 ± 4.67 | 4.08 ± 1.51 | 4.55 ± 1.98 | 1.99 ± 0.81 | | Sarcoidosis | 8.82 ± 5.17 | 1.77 ± 0.69 | 5.34 ± 3.08 | 1.28 ± 0.63 | | Chronic inflammation 1 | 10.80 | 9.13 | 5.33 | 5.12 | | Chronic inflammation 2 | 1.62 | 5.75 | 0.99 | 2.65 |
|
|
